Laboratory Evaluation of a SARS-CoV-2 RT-LAMP Test.
COVID-19
LMICs
RT-LAMP
RT-PCR
molecular diagnostic
performance
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
13 Jun 2023
13 Jun 2023
Historique:
received:
21
03
2023
revised:
30
05
2023
accepted:
08
06
2023
medline:
27
6
2023
pubmed:
27
6
2023
entrez:
27
6
2023
Statut:
epublish
Résumé
There is a need to have more accessible molecular diagnostic tests for the diagnosis of severe acute respiratory syndrome coronavirus 2 disease in low- and middle-income countries. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) may provide an attractive option as this technology does not require a complex infrastructure. In this study, the diagnostic performance of a SARS-CoV-2 RT-LAMP was evaluated using RT-PCR-confirmed clinical specimens of COVID-19-positive (n = 55) and -negative patients (n = 55) from the Netherlands. The observed sensitivity of the RT-LAMP test was 97.2% (95% CI: 82.4-98.0%) and the specificity was 100% (95% CI: 93.5-100%). The positive predictive value of the RT-LAMP was 100%, the negative predictive value 93.2% (95% CI: 84.3-97.3%), and the diagnostic accuracy was 96.4% (95% CI: 91.0-99.0%). The agreement between the RT-LAMP and the RT-PCR was "almost perfect" (κ-value: 0.92). The evaluated RT-LAMP might provide an attractive alternative molecular diagnostic tool for SARS-CoV-2 in resource limited settings.
Identifiants
pubmed: 37368738
pii: tropicalmed8060320
doi: 10.3390/tropicalmed8060320
pmc: PMC10302189
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Developping Countries Clinical Trials Partnership
ID : RIA2020EF-3012
Références
JAMA. 2020 Apr 28;323(16):1549-1550
pubmed: 32176764
Biosensors (Basel). 2022 Nov 27;12(12):
pubmed: 36551050
Microbiol Spectr. 2022 Dec 21;10(6):e0201222
pubmed: 36448777
Infection. 2023 Jan 2;:
pubmed: 36592297
Front Microbiol. 2022 Dec 22;13:1063414
pubmed: 36620063
MethodsX. 2023;10:102011
pubmed: 36643803
Life (Basel). 2022 Nov 21;12(11):
pubmed: 36431077
BMJ Open. 2016 Nov 14;6(11):e012799
pubmed: 28137831
J Infect Chemother. 2021 Feb;27(2):410-412
pubmed: 33214073
Viruses. 2022 Nov 25;14(12):
pubmed: 36560632
Analyst. 2021 Mar 7;146(5):1514-1528
pubmed: 33595550
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
PLoS One. 2023 Jan 26;18(1):e0279681
pubmed: 36701313
Nat Rev Microbiol. 2006 Sep;4(9 Suppl):S21-31
pubmed: 17034069
J Clin Virol. 2021 Jun;139:104821
pubmed: 33882373
PLoS One. 2023 Jan 25;18(1):e0277657
pubmed: 36696882
J Clin Virol Plus. 2023 Feb;3(1):100138
pubmed: 36683610
Expert Rev Mol Diagn. 2023 Jan;23(1):9-28
pubmed: 36695788
EBioMedicine. 2018 Nov;37:453-460
pubmed: 30396855
Int J Mol Sci. 2022 Oct 28;23(21):
pubmed: 36361893
Egypt J Immunol. 2023 Jan;30(1):14-19
pubmed: 36588449